TECENTRIQ: New Drug Trials Snapshot Posted

A new DRUG TRIALS SNAPSHOT FOR TECENTRIQ is now available.

TECENTRIQ is a drug for the treatment of a type of bladder cancer called urothelial carcinoma. TECENTRIQ may be used when:

• bladder cancer has spread or cannot be removed by surgery (advanced urothelial carcinoma) and,
• chemotherapy that contains platinum did not work or is no longer working.

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.